Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
批准号:
8383990
负责人:
Gulab Zode
金额:
$8.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2014-08-31
关键词:
Advisory CommitteesApoptosisApoptoticAqueous HumorAutophagocytosisAutopsyCell DeathCellsChronicClinicalDataDegradation PathwayDevelopmentDexamethasoneDiagnosisDiseaseEducational process of instructingEndoplasmic ReticulumEyeFailureFunctional disorderGRP78 geneGRP94GeneticGlaucomaHomeostasisHumanIndividualKnockout MiceLaboratoriesLaboratory ResearchLeadLearningLysosomesMentorsModelingMolecular ChaperonesMusMutationNerve DegenerationOcular HypertensionOptic NervePathogenesisPathway interactionsPatientsPhasePhenotypePhenylbutyratesPhosphorylationPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProcessProteinsResearch InstituteResistanceRetinal Ganglion CellsRisk FactorsRoleSirolimusSodium phenylbutyrateSteroidsTestingTissuesTopical applicationTrabecular meshwork structureTrainingTransgenic MiceTransgenic OrganismsWestern Blottingcareer developmentcommon treatmentendoplasmic reticulum stressexperiencegenetic risk assessmentimprovedinduced pluripotent stem cellinhibitor/antagonistinsightmouse modelmutantmyocilinnovelpreventprotein aggregateprotein degradationprotein misfoldingresponsesensorsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Primary open angle glaucoma (POAG), the most common form of glaucoma, is usually accompanied by elevated intraocular pressure (IOP) due to failure of the trabecular meshwork (TM) to maintain normal levels of aqueous humor outflow. We recently generated a novel transgenic murine model (Tg-MYOCY437H) that expresses mutant myocilin, a known leading genetic cause of POAG in humans and replicates human glaucoma phenotypes. Importantly, we have associated endoplasmic reticulum (ER) stress to the pathogenesis of glaucoma in Tg-MYOCY437H mice. Misfolded myocilin accumulates in the ER, induces ER stress and activates a protective unfolded protein response (UPR). Along with UPR activation, mutant myocilin also induces autophagy, a process of lysosomal degradation known to degrade protein aggregates. However, failure to eliminate myocilin aggregates possibly due to insufficient UPR and impaired autophagy, TM cells induce the ER stress-initiated apoptotic transcriptional factor, Chop, which may further worsen ER homeostasis and cause TM dysfunction/loss, elevating IOP and resulting in POAG. The current proposal will further investigate the role of chronic ER stress in the pathogenesis of myocilin as well as non-myocilin associated POAG. During the mentored phase, the proposed studies will determine whether failure to activate the protective UPR (Atf-6¿-/-) exacerbates glaucoma phenotypes, whereas interference with ER stress-induced apoptosis (Chop-/-) prevents glaucoma in Tg-MYOCY437H mice. In addition, we will investigate whether ER stress is activated in port-mortem TM tissues from POAG donors. During the independent phase, we will examine whether induction of ER stress in the TM is associated with elevation of IOP in a mouse model of dexamethasone-induced ocular hypertension. In addition, we will examine the role of autophagy in degradation of myocilin aggregates and will determine whether inducing autophagy by rapamycin will rescue the glaucoma of Tg-MYOCY437H mice. Specifically, the candidate will learn and generate new models of ER stress using Atf6¿ and Chop knockout mice, generate induced pluripotent stem cells (iPSCs)-derived trabecular meshwork- like cells from POAG patients, and characterize a dexamethasone-induced ocular hypertension mouse model in the laboratory of Dr. Val Sheffield. Additionally, during the mentored phase, the candidate will continue his professional and scientific career development through continual guidance from the advisory committee. He will attend scientific conferences, and collaborate with ER stress expert, Dr. Thomas Rutkowski and glaucoma clinical expert, Dr. Lee Alward. He will also acquire teaching experience. This project will facilitate continued technical, intellectul, and professional training of the candidate, and assist the candidate in the establishment of an independent research laboratory at an academic research institute.
PUBLIC HEALTH RELEVANCE: The successful completion of this project will lead to insight into elevated intraocular pressure, a major risk factor of the human blinding disorder, primary open angle glaucoma. The results will potentially improve diagnosis, genetic risk assessment and treatment of this common disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and characterization of an inducible model for myocilin POAG
-
批准号:10661911
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2023
-
负责人:Gulab Zode
-
依托单位:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
-
批准号:10202609
-
项目类别:
-
资助金额:$35.41万
-
财政年份:2018
-
负责人:Gulab Zode
-
依托单位:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
-
批准号:9788452
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2018
-
负责人:Gulab Zode
-
依托单位:
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
-
批准号:9124324
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2016
-
负责人:Gulab Zode
-
依托单位:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
-
批准号:10850091
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2016
-
负责人:Gulab Zode
-
依托单位:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
-
批准号:10445174
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2016
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8822297
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8813843
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:9039612
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2014
-
负责人:Gulab Zode
-
依托单位:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
-
批准号:8534133
-
项目类别:
-
资助金额:$8.77万
-
财政年份:2012
-
负责人:Gulab Zode
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: